KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
This Quarter Return
-4.59%
1 Year Return
+14.33%
3 Year Return
+109.21%
5 Year Return
+340.79%
10 Year Return
–
AUM
$54.4M
AUM Growth
+$54.4M
(-38%)
Cap. Flow
-$26.2M
Cap. Flow
% of AUM
-48.18%
Top 10 Holdings %
Top 10 Hldgs %
56.26%
Holding
47
New
–
Increased
–
Reduced
39
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
FNSR
Finisar Corp
FNSR
|
$2.36M |
| 2 |
NeoGenomics
NEO
|
$2.29M |
| 3 |
CY
Cypress Semiconductor
CY
|
$2.08M |
| 4 |
Vericel Corp
VCEL
|
$1.8M |
| 5 |
Twilio
TWLO
|
$1.63M |
Sector Composition
| 1 | Healthcare | 40.82% |
| 2 | Technology | 35.37% |
| 3 | Financials | 4.02% |
| 4 | Consumer Discretionary | 3.19% |
| 5 | Industrials | 2.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $3.97M | 7.3% | 207,781 -119,657 | -37% | -$2.29M |
|
2
Insulet
PODD
$23.9B
| $3.95M | 7.25% | 23,934 -8,695 | -27% | -$1.43M |
|
|
3
Twilio
TWLO
$16.2B
| $3.77M | 6.92% | 34,263 -14,781 | -30% | -$1.63M |
|
|
CY
4
DELISTED
Cypress Semiconductor
CY
| $3.72M | 6.84% | 159,460 -89,034 | -36% | -$2.08M |
|
|
5
Vericel Corp
VCEL
$1.83B
| $3M | 5.52% | 198,445 -118,634 | -37% | -$1.8M |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.85M | 5.23% | 104,462 -57,680 | -36% | -$1.57M |
|
7
Upland Software
UPLD
$81.4M
| $2.46M | 4.52% | 70,535 -40,078 | -36% | -$1.4M |
|
8
FIVE9
FIVN
$2.08B
| $2.39M | 4.38% | 44,400 -26,214 | -37% | -$1.41M |
|
9
CyberArk
CYBR
$22.8B
| $2.3M | 4.23% | 23,044 -14,339 | -38% | -$1.43M |
|
10
Omnicell
OMCL
$1.5B
| $2.21M | 4.07% | 30,617 -17,811 | -37% | -$1.29M |
|
11
AtriCure
ATRC
$1.84B
| $2.19M | 4.02% | 87,809 -46,887 | -35% | -$1.17M |
|
12
MaxLinear
MXL
$1.37B
| $2M | 3.67% | 89,316 -55,896 | -38% | -$1.25M |
|
13
Supernus Pharmaceuticals
SUPN
$2.53B
| $1.36M | 2.5% | 49,462 -27,930 | -36% | -$767K |
|
14
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.23M | 2.26% | 4,150 -300 | -7% | -$89.1K |
|
|
SRGA
15
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.18M | 2.18% | 415,577 -306,820 | -42% | -$874K |
|
16
Commault Systems
CVLT
$8.3B
| $1.16M | 2.13% | 25,962 -16,218 | -38% | -$725K |
|
|
XENT
17
DELISTED
Intersect ENT, Inc
XENT
| $1.15M | 2.11% | 67,390 -65,534 | -49% | -$1.11M |
|
18
Ligand Pharmaceuticals
LGND
$3.15B
| $1.05M | 1.94% | 10,578 -3,685 | -26% | -$367K |
|
19
Apple
AAPL
$3.45T
| $1.01M | 1.85% | 4,494 | – | – |
|
20
Procter & Gamble
PG
$368B
| $671K | 1.23% | 5,394 -472 | -8% | -$58.7K |
|
21
Invesco QQQ Trust
QQQ
$364B
| $647K | 1.19% | 3,425 | – | – |
|
22
Aflac
AFL
$57.2B
| $622K | 1.14% | 11,895 -903 | -7% | -$47.2K |
|
23
Marriott International Class A Common Stock
MAR
$72.7B
| $608K | 1.12% | 4,888 -388 | -7% | -$48.3K |
|
24
JPMorgan Chase
JPM
$829B
| $594K | 1.09% | 5,049 -428 | -8% | -$50.4K |
|
25
Vanguard Total Stock Market ETF
VTI
$526B
| $574K | 1.05% | 3,800 | – | – |
|